Oral fingolimod reduces glutamate-mediated intracortical excitability in relapsing-remitting multiple sclerosis. Landi D, Vollaro S, Pellegrino G, Mulas D, Ghazaryan A, Falato E, Pasqualetti P, Rossini P, Filippi M Clin Neurophysiol. 2014 Jun 19. PMID: 25022794. Abstract CommentRecommendBookmarkWatch